LAM
BSX icon

L2 Asset Management’s Boston Scientific BSX Stock Holding History

L2 Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Buy
8,487
+486
+6% +$26.4K 0.04% 312
2026
Q1 		$502K Buy
8,001
+544
+7% +$43.5K 0.05% 235
2025
Q4 		$711K Buy
7,457
+560
+8% +$54.9K 0.1% 175
2025
Q3 		$673K Buy
6,897
+271
+4% +$28.1K 0.1% 178
2025
Q2 		$712K Buy
6,626
+344
+5% +$34.8K 0.12% 152
2025
Q1 		$634K Buy
6,282
+577
+10% +$58.1K 0.13% 126
2024
Q4 		$510K Sell
5,705
-112
-2% -$9.86K 0.11% 132
2024
Q3 		$487K Buy
5,817
+201
+4% +$15.8K 0.13% 113
2024
Q2 		$432K Buy
5,616
+528
+10% +$38.6K 0.13% 123
2024
Q1 		$348K Buy
5,088
+357
+8% +$23K 0.11% 140
2023
Q4 		$273K Buy
4,731
+4,479
+1,777% +$239K 0.11% 138
2023
Q3 		$217K Buy
+252
New +$13.2K 0.1% 153

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

L2 Asset Management's BSX Position: Q2 2026 in Review

L2 Asset Management increased its Boston Scientific (BSX) stake by 6.1% in Q2 2026, buying an estimated $26.4K and bringing the position to 8,487 shares worth $362K. The position accounts for 0.04% of the portfolio, ranked #312.

L2 Asset Management first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $712K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • L2 Asset Management held 8,487 shares of Boston Scientific worth $362K as of Q2 2026.
  • L2 Asset Management bought 486 Boston Scientific shares in Q2 2026, an estimated $26.4K.
  • Boston Scientific made up 0.04% of L2 Asset Management's portfolio in Q2 2026, its #312 holding.
  • L2 Asset Management first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • L2 Asset Management's Boston Scientific position peaked at $712K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.